Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
Monika Olczak-Pruc, Damian Swieczkowski, Jerzy R Ladny, Michal Pruc, Raul Juarez-Vela, Zubaid Rafique, Frank W Peacock, Lukasz Szarpak
Nutrients, doi:10.3390/nu14194217
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died, and the medical system has faced significant difficulties. Our purpose was to perform a meta-analysis to estimate the effect of vitamin C on in-hospital mortality and the ICU or hospital length of stay for patients diagnosed with COVID-19. We conducted a systematic review with meta-analysis in the following databases: PubMed, Web of Science, Scopus and Cochrane Central Register of Controlled Trials. We included studies that evaluated the effect of vitamin C supplementation, compared with standard treatment in COVID-19 patients who are ≥18 y of age. Nineteen trials were included in the meta-analysis. In-hospital mortality with and without vitamin C supplementation was 24.1% vs. 33.9% (OR = 0.59; 95%CI: 0.37 to 0.95; p = 0.03), respectively. Sub-analysis showed that, in randomized clinical trials, in-hospital mortality varied and amounted to 23.9% vs. 35.8% (OR = 0.44; 95%CI: 0.25 to 0.76; p = 0.003), respectively. In the non-randomized trials, in-hospital mortality was 24.2% vs. 33.5% (OR = 0.72; 95%CI: 0.38 to 1.39; p = 0.33), respectively. The ICU length of stay was longer in patients treated with vitamin C vs. standard therapy, 11.1 (7.3) vs. 8.3 (4.7) days (MD = 1.91; 95%CI: 0.89 to 2.93; p < 0.001), respectively. Acute kidney injury in patients treated with and without vitamin C varied and amounted to 27.8% vs. 45.0% (OR = 0.56; 95%CI: 0.40 to 0.78; p < 0.001), respectively. There were no differences in the frequency of other adverse events among patients' treatment with and without vitamin C (all p > 0.05). The use of vitamin C reduces hospital mortality. The length of stay in the ICU is longer among patients treated with vitamin C. In terms of patient safety, vitamin C has an acceptable profile. Low doses of vitamin C are effective and safe. Despite some evidence of the usefulness of vitamin C in modifying the course of COVID-19, it is too early to modify guidelines and recommendations. Further studies, in particular randomized clinical trials, are necessary.
Conflicts of Interest: The authors declare no conflict of interest.
References
Al Sulaiman, Aljuhani, Saleh, Badreldin, Al Harthi et al., Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: A propensity score matched study, Sci. Rep,
doi:10.1038/s41598-021-96703-yAo, Li, Yuan, Wang, Nasr et al., Intravenous vitamin C use and risk of severity and mortality in COVID-19: A systematic review and meta-analysis, Nutr. Clin. Pract,
doi:10.1002/ncp.10832Bae, Kim, Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19, Molecules,
doi:10.3390/molecules25225346Beigmohammadi, Bitarafan, Hoseindokht, Abdollahi, Amoozadeh et al., The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: A randomized clinical trial, Trials,
doi:10.1186/s13063-021-05795-4Bhowmik, Barek, Aziz, Islam, Impact of high-dose vitamin C on the mortality, severity, and duration of hospital stay in COVID-19 patients: A meta-analysis, Health Sci. Rep,
doi:10.1002/hsr2.762Biancatelli, Berrill, Catravas, Marik, Quercetin, Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19), Front. Immunol,
doi:10.3389/fimmu.2020.01451Borges, Gennari-Felipe, Dias, Hatanaka, Melatonin et al., Potential Adjuvant Treatment for COVID-19 Patients, Front. Nutr,
doi:10.3389/fnut.2021.821824Carr, Rowe, Factors Affecting Vitamin C Status and Prevalence of Deficiency: A Global Health Perspective, Nutrients,
doi:10.3390/nu12071963Cerullo, Negro, Parimbelli, Pecoraro, Perna et al., The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19, Front. Immunol,
doi:10.3389/fimmu.2020.574029Coppock, Violet, Vasquez, Belden, Foster et al., Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial, Life,
doi:10.3390/life12030453Corrao, Mallaci Bocchio, Lo Monaco, Natoli, Cavezzi et al., Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc, Nutrients,
doi:10.3390/nu13041261Darban, Malek, Memarian, Gohari, Kiani et al., Efficacy of High Dose Vitamin C, Melatonin and Zinc in Iranian Patients with Acute Respiratory Syndrome due to Coronavirus Infection: A Pilot Randomized Trial, J. Cell. Mol. Anesth
Fashner, Ericson, Werner, Treatment of the common cold in children and adults, Am. Fam. Physician
Ferrón-Celma, Mansilla, Hassan, Garcia-Navarro, Comino et al., Effect of vitamin C administration on neutrophil apoptosis in septic patients after abdominal surgery, J. Surg. Res,
doi:10.1016/j.jss.2008.04.024Firouzi, Pahlavani, Navashenaq, Clayton, Beigmohammadi et al., The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients, Clin. Nutr. Open Sci
Gao, Xu, Wang, Lv, Ma et al., The efficiency and safety of high-dose vitamin C in patients with COVID-19: A retrospective cohort study, Aging,
doi:10.18632/aging.202557Gavriatopoulou, Ntanasis-Stathopoulos, Korompoki, Fotiou, Migkou et al., Emerging treatment strategies for COVID-19 infection, Clin. Exp. Med,
doi:10.1007/s10238-020-00671-yGavrielatou, Xourgia, Xixi, Mantelou, Ischaki et al., Effect of Vitamin C on Clinical Outcomes of Critically Ill Patients with COVID-19: An Observational Study and Subsequent Meta-Analysis, Front. Med,
doi:10.3389/fmed.2022.814587Gröber, Holick, The coronavirus disease (COVID-19)-A supportive approach with selected micronutrients, Int. J. Vitam. Nutr. Res,
doi:10.1024/0300-9831/a000693Hakamifard, Soltani, Maghsoudi, Rismanbaf, Aalinezhad et al., The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial, Immunopathol. Persa
Hess, Halalau, Dokter, Paydawy, Karabon et al., High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19, Intern. Emerg. Med,
doi:10.1007/s11739-022-02954-6Higgins, Thompson, Deeks, Altman, Measuring inconsistency in meta-analyses, BMJ
Hozo, Djulbegovic, Hozo, Estimating the mean and variance from the median, range, and the size of a sample, BMC Med. Res. Methodol,
doi:10.1186/1471-2288-5-13Kaźmierczak-Bara Ńska, Boguszewska, Adamus-Grabicka, Karwowski, Two Faces of Vitamin C-Antioxidative and Pro-Oxidative Agent, Nutrients,
doi:10.3390/nu12051501Kocot, Luchowska-Kocot, Kiełczykowska, Musik, Kurzepa, Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?, Nutrients,
doi:10.3390/nu9070659Kumari, Dembra, Dembra, Bhawna, Gul et al., The Role of Vitamin C as Adjuvant Therapy in COVID-19, Cureus,
doi:10.7759/cureus.11779Lamontagne, Masse, Menard, Sprague, Pinto et al., Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit, N. Engl. J. Med,
doi:10.1056/NEJMoa2200644Li, Ching, Hipple, Lopez, Sahibzada et al., Use of Intravenous Vitamin C in Critically Ill Patients with COVID-19 Infection, J. Pharm. Pract,
doi:10.1177/08971900211015052Liugan, Carr, Vitamin C and neutrophil function: Findings from randomized controlled trials, Nutrients,
doi:10.3390/nu11092102Majidi, Rabbani, Gholami, Gholamalizadeh, Bourbour et al., The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial, Front. Immunol,
doi:10.3389/fimmu.2021.717816Manning, Mitchell, Appadurai, Shakya, Pierce et al., Vitamin C promotes maturation of T-cells, Antioxid. Redox Signal,
doi:10.1089/ars.2012.4988Mcguinness, Higgins, Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments, Res. Synth. Methods,
doi:10.1002/jrsm.1411Migliorini, Vaishya, Eschweiler, Oliva, Hildebrand et al., Vitamins C and D and COVID-19 Susceptibility, Severity and Progression: An Evidence Based Systematic Review, Medicina,
doi:10.3390/medicina58070941Miranda-Massari, Toro, Loh, Rodriguez, Borges et al., The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19, Life
Muralidar, Ambi, Sekaran, Krishnan, The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2, Biochimie,
doi:10.1016/j.biochi.2020.09.018Page, Mckenzie, Bossuyt, Boutron, Hoffmann et al., The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, BMJ,
doi:10.1136/bmj.n71Pedrosa, Barros, Leite-Lais, Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review, Clin. Nutr. ESPEN,
doi:10.1016/j.clnesp.2021.11.003Pourkarim, Pourtaghi-Anvarian, Rezaee, Molnupiravir: A new candidate for COVID-19 treatment, Pharmacol. Res. Perspect,
doi:10.1002/prp2.909Rawat, Roy, Maitra, Gulati, Khanna et al., Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials, Diabetes Metab. Syndr,
doi:10.1016/j.dsx.2021.102324Shahbaz, Fatima, Basharat, Bibi, Yu et al., Role of vitamin C in preventing of COVID-19 infection, progression and severity, AIMS Microbiol,
doi:10.3934/microbiol.2022010Shakoor, Feehan, Al Dhaheri, Ali, Platat et al., Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?, Maturitas
Shilotri, Bhat, Effect of mega doses of vitamin C on bactericidal ativity of leukocytes, Am. J. Clin. Nutr
Siahkali, Zarezade, Koolaji, Seyed Alinaghi, Zendehdel et al., Safety and effectiveness of high-dose vitamin C in patients with COVID-19: A randomized open-label clinical trial, Eur. J. Med. Res
Sterne, Hernán, Reeves, Savović, Berkman et al., ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions, BMJ
Sterne, Savović, Page, Elbers, Blencowe et al., RoB 2: A revised tool for assessing risk of bias in randomised trials, BMJ,
doi:10.1136/bmj.l4898Suna, Melahat, Murat, Figen, Ayperi, Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia, Med. Clin,
doi:10.1016/j.medcli.2021.04.010Szarpak, Pruc, Gasecka, Jaguszewski, Michalski et al., Should we supplement zinc in COVID-19 patients? Evidence from a meta-analysis, Pol. Arch. Intern. Med,
doi:10.20452/pamw.16048Teafatiller, Agrawal, De Robles, Rahmatpanah, Subramanian et al., Vitamin C Enhances Antiviral Functions of Lung Epithelial Cells, Biomolecules,
doi:10.3390/biom11081148Tehrani, Yadegarynia, Abrishami, Moradi, Gharaei et al., An investigation into the Effects of Intravenous Vitamin C on Pulmonary CT Findings and Clinical Outcomes of Patients with COVID 19 Pneumonia A Randomized Clinical Trial, Urol. J
Thomas, Patel, Bittel, Wolski, Wang et al., Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients with SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial, JAMA Netw. Open,
doi:10.1001/jamanetworkopen.2021.0369Vollbracht, Kraft, Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue, Nutrients,
doi:10.3390/nu13041154Vollbracht, Kraft, Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C, Front. Pharmacol,
doi:10.3389/fphar.2022.899198Zhang, Rao, Li, Zhu, Liu et al., Pilot trial of high-dose vitamin C in critically ill COVID-19 patients, Ann. Intensive Care,
doi:10.1186/s13613-020-00792-3Zhao, Liu, Liu, Peng, Huang et al., High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study, Front. Pharmacol,
doi:10.3389/fphar.2021.638556Zheng, Chen, Jiang, Guo, Luo et al., No significant benefit of moderate-dose vitamin C on severe COVID-19 cases, Open Med,
doi:10.1515/med-2021-0361DOI record:
{
"DOI": "10.3390/nu14194217",
"ISSN": [
"2072-6643"
],
"URL": "http://dx.doi.org/10.3390/nu14194217",
"abstract": "<jats:p>Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died, and the medical system has faced significant difficulties. Our purpose was to perform a meta-analysis to estimate the effect of vitamin C on in-hospital mortality and the ICU or hospital length of stay for patients diagnosed with COVID-19. We conducted a systematic review with meta-analysis in the following databases: PubMed, Web of Science, Scopus and Cochrane Central Register of Controlled Trials. We included studies that evaluated the effect of vitamin C supplementation, compared with standard treatment in COVID-19 patients who are ≥18 y of age. Nineteen trials were included in the meta-analysis. In-hospital mortality with and without vitamin C supplementation was 24.1% vs. 33.9% (OR = 0.59; 95%CI: 0.37 to 0.95; p = 0.03), respectively. Sub-analysis showed that, in randomized clinical trials, in-hospital mortality varied and amounted to 23.9% vs. 35.8% (OR = 0.44; 95%CI: 0.25 to 0.76; p = 0.003), respectively. In the non-randomized trials, in-hospital mortality was 24.2% vs. 33.5% (OR = 0.72; 95%CI: 0.38 to 1.39; p = 0.33), respectively. The ICU length of stay was longer in patients treated with vitamin C vs. standard therapy, 11.1 (7.3) vs. 8.3 (4.7) days (MD = 1.91; 95%CI: 0.89 to 2.93; p < 0.001), respectively. Acute kidney injury in patients treated with and without vitamin C varied and amounted to 27.8% vs. 45.0% (OR = 0.56; 95%CI: 0.40 to 0.78; p < 0.001), respectively. There were no differences in the frequency of other adverse events among patients’ treatment with and without vitamin C (all p > 0.05). The use of vitamin C reduces hospital mortality. The length of stay in the ICU is longer among patients treated with vitamin C. In terms of patient safety, vitamin C has an acceptable profile. Low doses of vitamin C are effective and safe. Despite some evidence of the usefulness of vitamin C in modifying the course of COVID-19, it is too early to modify guidelines and recommendations. Further studies, in particular randomized clinical trials, are necessary.</jats:p>",
"alternative-id": [
"nu14194217"
],
"author": [
{
"affiliation": [],
"family": "Olczak-Pruc",
"given": "Monika",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-5648-4652",
"affiliation": [],
"authenticated-orcid": false,
"family": "Swieczkowski",
"given": "Damian",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-4167-1962",
"affiliation": [],
"authenticated-orcid": false,
"family": "Ladny",
"given": "Jerzy R.",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-2140-9732",
"affiliation": [],
"authenticated-orcid": false,
"family": "Pruc",
"given": "Michal",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-3597-2048",
"affiliation": [],
"authenticated-orcid": false,
"family": "Juarez-Vela",
"given": "Raul",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Rafique",
"given": "Zubaid",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-2730-6742",
"affiliation": [],
"authenticated-orcid": false,
"family": "Peacock",
"given": "Frank W.",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-0973-5455",
"affiliation": [],
"authenticated-orcid": false,
"family": "Szarpak",
"given": "Lukasz",
"sequence": "additional"
}
],
"container-title": "Nutrients",
"container-title-short": "Nutrients",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
10,
11
]
],
"date-time": "2022-10-11T04:50:01Z",
"timestamp": 1665463801000
},
"deposited": {
"date-parts": [
[
2022,
10,
11
]
],
"date-time": "2022-10-11T05:40:29Z",
"timestamp": 1665466829000
},
"indexed": {
"date-parts": [
[
2022,
10,
11
]
],
"date-time": "2022-10-11T06:15:47Z",
"timestamp": 1665468947790
},
"is-referenced-by-count": 0,
"issue": "19",
"issued": {
"date-parts": [
[
2022,
10,
10
]
]
},
"journal-issue": {
"issue": "19",
"published-online": {
"date-parts": [
[
2022,
10
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
10,
10
]
],
"date-time": "2022-10-10T00:00:00Z",
"timestamp": 1665360000000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/2072-6643/14/19/4217/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "4217",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2022,
10,
10
]
]
},
"published-online": {
"date-parts": [
[
2022,
10,
10
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"DOI": "10.1016/j.biochi.2020.09.018",
"doi-asserted-by": "publisher",
"key": "ref1"
},
{
"DOI": "10.1007/s10238-020-00671-y",
"doi-asserted-by": "publisher",
"key": "ref2"
},
{
"DOI": "10.20452/pamw.16048",
"doi-asserted-by": "publisher",
"key": "ref3"
},
{
"DOI": "10.1002/prp2.909",
"doi-asserted-by": "publisher",
"key": "ref4"
},
{
"DOI": "10.3390/molecules25225346",
"doi-asserted-by": "publisher",
"key": "ref5"
},
{
"DOI": "10.1016/j.maturitas.2020.08.003",
"doi-asserted-by": "publisher",
"key": "ref6"
},
{
"DOI": "10.1080/07315724.2003.10719272",
"doi-asserted-by": "publisher",
"key": "ref7"
},
{
"DOI": "10.3390/nu9070659",
"doi-asserted-by": "publisher",
"key": "ref8"
},
{
"DOI": "10.1096/fasebj.13.9.1007",
"doi-asserted-by": "publisher",
"key": "ref9"
},
{
"DOI": "10.3390/nu12051501",
"doi-asserted-by": "publisher",
"key": "ref10"
},
{
"DOI": "10.1093/ajcn/30.7.1077",
"doi-asserted-by": "publisher",
"key": "ref11"
},
{
"DOI": "10.3390/nu11092102",
"doi-asserted-by": "publisher",
"key": "ref12"
},
{
"DOI": "10.1016/j.jss.2008.04.024",
"doi-asserted-by": "publisher",
"key": "ref13"
},
{
"DOI": "10.1089/ars.2012.4988",
"doi-asserted-by": "publisher",
"key": "ref14"
},
{
"DOI": "10.12968/bjcn.2013.18.Sup12.S6",
"doi-asserted-by": "publisher",
"key": "ref15"
},
{
"DOI": "10.3390/biom11081148",
"doi-asserted-by": "publisher",
"key": "ref16"
},
{
"DOI": "10.3390/life11121341",
"doi-asserted-by": "publisher",
"key": "ref17"
},
{
"DOI": "10.3389/fimmu.2020.574029",
"doi-asserted-by": "publisher",
"key": "ref18"
},
{
"article-title": "Treatment of the common cold in children and adults",
"author": "Fashner",
"first-page": "153",
"journal-title": "Am. Fam. Physician",
"key": "ref19",
"volume": "86",
"year": "2012"
},
{
"DOI": "10.3390/nu12071963",
"doi-asserted-by": "publisher",
"key": "ref20"
},
{
"DOI": "10.1001/jama.2019.11643",
"doi-asserted-by": "publisher",
"key": "ref21"
},
{
"DOI": "10.7326/0003-4819-140-7-200404060-00010",
"doi-asserted-by": "publisher",
"key": "ref22"
},
{
"DOI": "10.3389/fimmu.2020.01451",
"doi-asserted-by": "publisher",
"key": "ref23"
},
{
"DOI": "10.3390/nu13041172",
"doi-asserted-by": "publisher",
"key": "ref24"
},
{
"DOI": "10.3390/nu13041154",
"doi-asserted-by": "publisher",
"key": "ref25"
},
{
"DOI": "10.1136/bmj.n71",
"doi-asserted-by": "publisher",
"key": "ref26"
},
{
"DOI": "10.1136/bmj.l4898",
"doi-asserted-by": "publisher",
"key": "ref27"
},
{
"DOI": "10.1136/bmj.i4919",
"doi-asserted-by": "publisher",
"key": "ref28"
},
{
"DOI": "10.1002/jrsm.1411",
"doi-asserted-by": "publisher",
"key": "ref29"
},
{
"DOI": "10.1186/1471-2288-5-13",
"doi-asserted-by": "publisher",
"key": "ref30"
},
{
"DOI": "10.1136/bmj.327.7414.557",
"doi-asserted-by": "publisher",
"key": "ref31"
},
{
"DOI": "10.1038/s41598-021-96703-y",
"doi-asserted-by": "publisher",
"key": "ref32"
},
{
"DOI": "10.1186/s13063-021-05795-4",
"doi-asserted-by": "publisher",
"key": "ref33"
},
{
"DOI": "10.3390/life12030453",
"doi-asserted-by": "publisher",
"key": "ref34"
},
{
"article-title": "Efficacy of High Dose Vitamin C, Melatonin and Zinc in Iranian Patients with Acute Respiratory Syndrome due to Coronavirus Infection: A Pilot Randomized Trial",
"author": "Darban",
"first-page": "164",
"journal-title": "J. Cell. Mol. Anesth.",
"key": "ref35",
"volume": "6",
"year": "2021"
},
{
"DOI": "10.18632/aging.202557",
"doi-asserted-by": "publisher",
"key": "ref36"
},
{
"DOI": "10.3389/fmed.2022.814587",
"doi-asserted-by": "publisher",
"key": "ref37"
},
{
"article-title": "The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial",
"author": "Hakamifard",
"first-page": "e08",
"journal-title": "Immunopathol. Persa.",
"key": "ref38",
"volume": "8",
"year": "2022"
},
{
"DOI": "10.1007/s11739-022-02954-6",
"doi-asserted-by": "publisher",
"key": "ref39"
},
{
"DOI": "10.7759/cureus.11779",
"doi-asserted-by": "publisher",
"key": "ref40"
},
{
"DOI": "10.1177/08971900211015052",
"doi-asserted-by": "publisher",
"key": "ref41"
},
{
"DOI": "10.3389/fimmu.2021.717816",
"doi-asserted-by": "publisher",
"key": "ref42"
},
{
"DOI": "10.1186/s40001-021-00490-1",
"article-title": "Safety and effectiveness of high-dose vitamin C in patients with COVID-19: A randomized open-label clinical trial",
"author": "Siahkali",
"doi-asserted-by": "crossref",
"first-page": "20",
"journal-title": "Eur. J. Med. Res.",
"key": "ref43",
"volume": "26",
"year": "2021"
},
{
"DOI": "10.5455/annalsmedres.2020.10.1043",
"doi-asserted-by": "publisher",
"key": "ref44"
},
{
"DOI": "10.1016/j.medcli.2021.04.010",
"doi-asserted-by": "publisher",
"key": "ref45"
},
{
"article-title": "An investigation into the Effects of Intravenous Vitamin C on Pulmonary CT Findings and Clinical Outcomes of Patients with COVID 19 Pneumonia A Randomized Clinical Trial",
"author": "Tehrani",
"first-page": "6863",
"journal-title": "Urol. J.",
"key": "ref46",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.1001/jamanetworkopen.2021.0369",
"doi-asserted-by": "publisher",
"key": "ref47"
},
{
"DOI": "10.1186/s13613-020-00792-3",
"doi-asserted-by": "publisher",
"key": "ref48"
},
{
"DOI": "10.3389/fphar.2021.638556",
"doi-asserted-by": "publisher",
"key": "ref49"
},
{
"DOI": "10.1515/med-2021-0361",
"doi-asserted-by": "publisher",
"key": "ref50"
},
{
"DOI": "10.1056/NEJMoa2200644",
"doi-asserted-by": "publisher",
"key": "ref51"
},
{
"DOI": "10.1016/j.clnesp.2021.11.003",
"doi-asserted-by": "publisher",
"key": "ref52"
},
{
"DOI": "10.3934/microbiol.2022010",
"doi-asserted-by": "publisher",
"key": "ref53"
},
{
"DOI": "10.3389/fnut.2021.821824",
"doi-asserted-by": "publisher",
"key": "ref54"
},
{
"DOI": "10.3389/fphar.2022.899198",
"doi-asserted-by": "publisher",
"key": "ref55"
},
{
"DOI": "10.1024/0300-9831/a000693",
"doi-asserted-by": "publisher",
"key": "ref56"
},
{
"DOI": "10.1002/ncp.10832",
"doi-asserted-by": "publisher",
"key": "ref57"
},
{
"DOI": "10.3390/medicina58070941",
"doi-asserted-by": "publisher",
"key": "ref58"
},
{
"DOI": "10.1016/j.dsx.2021.102324",
"doi-asserted-by": "publisher",
"key": "ref59"
},
{
"DOI": "10.3389/fmed.2020.559811",
"doi-asserted-by": "publisher",
"key": "ref60"
},
{
"DOI": "10.1002/hsr2.762",
"doi-asserted-by": "publisher",
"key": "ref61"
},
{
"DOI": "10.3390/nu13041261",
"doi-asserted-by": "publisher",
"key": "ref62"
},
{
"DOI": "10.1016/j.clnesp.2022.05.026",
"doi-asserted-by": "publisher",
"key": "ref63"
},
{
"DOI": "10.1016/j.nutos.2022.06.006",
"doi-asserted-by": "publisher",
"key": "ref64"
}
],
"reference-count": 64,
"references-count": 64,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/2072-6643/14/19/4217"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Food Science",
"Nutrition and Dietetics"
],
"subtitle": [],
"title": "Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis",
"type": "journal-article",
"volume": "14"
}
